InvestorsHub Logo
Followers 139
Posts 6806
Boards Moderated 0
Alias Born 03/20/2012

Re: Stowe post# 97586

Monday, 11/15/2021 6:58:33 PM

Monday, November 15, 2021 6:58:33 PM

Post# of 118360
Oh yes okay got ya! Sorry. Yes it's possible that assessment may remain undisclosed to the public market and we may never see it being released. The company may even have NDAs with individuals, companies and in this case a University who they may be sharing it with for various reasons. And yes I agree the third party assessment most likely played a big roll in the whole deal that was drawn up for the acquisition of Canary with Dr. Lander being involved and the agreement between the company and Cornell University with Dr. Shahin Rafii, his lab and staff to participate with Regen BioPharma's endeavors. The assessment for the NR2F6 IP and patents were being focused on in the assessment as well. So I'm sure all of this tied in with being one of the main reasons why the assessment was needed. The other factor that may have been in play here for getting the assessment done... was to evaluate the prospects for a JV/Partnership with Eli Lilly. So it's very obvious this was a very pivotal and essential thing which needed to be done for so many important business reasons. smile

Blessings and best wishes,
LoveAndLight smile